Sanofi Commits $20 Billion to U.S. R&D and Manufacturing by 2030

Sanofi announced plans to invest at least $20 billion in the United States by 2030, focused on increasing manufacturing and research & development (R&D) capacity.1245

The investment aims to support the potential launch of numerous new first- or best-in-class medicines over the next several years.35

Sanofi expects the investment to create a significant number of high-paying jobs in multiple U.S. states, although specific figures were not disclosed.35

Funds will be allocated both to direct expansion of Sanofi-owned sites and to partnerships with other domestic manufacturers.35

This move aligns Sanofi with other major pharmaceutical firms increasing U.S. investments amid recent political pressures on the pharmaceutical supply chain and incentives for domestic production.3

The company's plans include substantially increasing U.S. R&D spending to accelerate scientific innovation.5

Sources:

1. https://insights.citeline.com/scrip/scrip/business/manufacturing/in-brief-sanofi-commits-20bn-to-us-rd-and-manufacturing-by-2030-GF2N36KMKFDP5OJK5P3EOK5SVU/

2. https://www.contractpharma.com/breaking-news/sanofi-to-invest-20b-in-the-u-s-through-2030/

3. https://www.biospace.com/business/sanofi-hops-aboard-us-manufacturing-blitz-with-20b-commitment

4. https://www.news.sanofi.us/2025-05-14-Sanofi-to-invest-at-least-20-billion-in-the-US-through-2030,-growing-investments-in-science-and-expanding-domestic-manufacturing

5. https://www.americanpharmaceuticalreview.com/1315-News/619348-Sanofi-Announces-20B-Investment-in-the-U-S-Through-2030/